摘要
概述并精辟解析2015年全球制药行业发生的重大事件,包括药品定价、孤儿药研发、美国FDA优先审评凭证制度、药品研发管线缩减以及正在持续运作的并购。并展望未来,预测2016年有望上市的新药。
These eagle＇s-eye overview of the drug industry in 2015 provides some insight into some of last year＇s top stories, including drug pricing, orphan drug development, the FDA＇s priority review voucher system, pipeline attrition, and the ongoing movement in M＆A. We also take a look into the crystal ball and anticipate the new drugs that may reach the market in 2016.
出处
《药学进展》
CAS
2016年第8期627-634,共8页
Progress in Pharmaceutical Sciences
关键词
孤儿药
优先审评
药品定价
产品研发中止
orphan drug
priority review
drug pricing
product discontinuation
